These alterations impair antigen presentation and cytotoxic T-cell infiltration, creating a protumorigenic niche that facilitates immune evasion and may contribute to reduced responsiveness to PD-1 blockade in ulcer-related cSCC [19,49,53,54,55]. The gene discussed is PDCD1; the disease is skin squamous cell carcinoma.